MedPath

Single-sided Deafness and Cochlear Implantation

Completed
Conditions
Hearing Loss, Unilateral
Hearing Loss, Sensorineural
Hearing Loss, Cochlear
Labyrinthitis
Hearing Loss, Sudden
Hearing Loss in Left Ear
Hearing Loss
Hearing Loss in Right Ear
Interventions
Device: Cochlear implantation
Registration Number
NCT05052944
Lead Sponsor
Johns Hopkins University
Brief Summary

This observational study evaluates the effects of cochlear implantation in patients with deafness in one ear.

Detailed Description

Cochlear implant (CI) technology has been widely used for individuals with bilateral sensorineural hearing loss to improve the ability to perceive sound by bypassing the damaged portion of the inner ear. Recently in the U.S., Cochlear implantation has also been approved by the FDA for treatment of single-sided deafness. By restoring binaural hearing, cochlear implantation in unilateral hearing loss may improve hearing in noise and sound localization, however its audiologic outcomes and quality of life impact for patients remain incompletely understood.

This study aims to establish a prospective database to track and quantify the change in general health status, tinnitus severity, spatial hearing ability, and difficulty with communication in noise after unilateral cochlear implantation in patients with SSD undergoing routine medical and audiologic evaluation at the Johns Hopkins Cochlear Implant Center. Study participants will complete survey questionnaires and undergo standard-of-care audiological evaluation before and after cochlear implantation. Data collected in this study will be invaluable in gaining an in-depth understanding of the effects of cochlear implantation in patients with SSD in the context of current FDA guidelines, and lead to better counseling and patient selection for this treatment modality.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • For individuals ages 18 years-old and above, limited benefit from unilateral amplification is defined by test scores of 5% correct or less on monosyllabic consonant-nucleus-consonant (CNC) words in quiet when tested in the ear to be implanted alone.
  • Before implantation with a cochlear implant, individuals with SSD or AHL must have at least 1-month experience wearing a Contra Lateral Routing of Signal (CROS) hearing aid or other relevant device and not show any subjective benefit.
  • Medical and surgical clearance for cochlear implantation.
Read More
Exclusion Criteria
  • Not meeting FDA candidacy criteria for cochlear implantation in SSD
  • Inability to perform audiologic tasks (e.g. non-English speaking)
  • Medical or surgical contraindication to general anesthesia or cochlear implant surgery
  • Does not wish to participate
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cochlear implant recipientsCochlear implantationPatients with single-sided deafness undergoing cochlear implantation
Primary Outcome Measures
NameTimeMethod
Change in Speech recognition in noiseBaseline and up to 1 year post-implantation

Change in Speech recognition in noise will be assessed using the percent correct on AzBio with multitalker babble at 8dB signal-to-noise ratio.

Change in Speech recognition in quietBaseline and up to 1 year post-implantation

Change in Speech recognition in quiet will be assessed using the percent correct on Consonant-Noun-Consonant words and phonemes.

Secondary Outcome Measures
NameTimeMethod
Change in Tinnitus handicap as assessed by the Tinnitus Handicap InventoryBaseline and up to 1 year post-implantation

Score on Tinnitus Handicap Inventory. Range: 0-100. Higher score signifies more handicap due to tinnitus.

Change in Health utility as assessed by the Health Utility IndexBaseline and up to 1 year post-implantation

Score on Health Utility Index. Range: 0-1.0. Lower score signifies lower health utility.

Change in Hearing aid benefit as assessed by the Abbreviated Profile of Hearing Aid BenefitBaseline and up to 1 year post-implantation

Score on Abbreviated Profile of Hearing Aid Benefit. Range: 0-100. Higher score signifies more frequent problems with hearing.

Change in Spatial hearing as assessed by the Spatial Hearing QuestionnaireBaseline and up to 1 year post-implantation

Score on Spatial Hearing Questionnaire. Range: 0-100. Higher score signifies less handicap related to sound localization.

Trial Locations

Locations (5)

Johns Hopkins Bayview

🇺🇸

Baltimore, Maryland, United States

Johns Hopkins Outpatient Center

🇺🇸

Baltimore, Maryland, United States

Johns Hopkins Suburban

🇺🇸

Bethesda, Maryland, United States

Johns Hopkins White Marsh

🇺🇸

Nottingham, Maryland, United States

Johns Hopkins Greenspring Station

🇺🇸

Lutherville-Timonium, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath